Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 666,664 shares at $20.05 ($13.8M) on 2024-11-05, disclosed to the SEC on 2024-11-07.
Scheduled sale ($13.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.05 | 63,798 | $1.3M | 9.2% |
| 2 | $20.05 | 63,798 | $1.3M | 9.2% |
| 3 | $20.07 | 81,114 | $1.6M | 11.8% |
| 4 | $20.07 | 81,114 | $1.6M | 11.8% |
| 5 | $21.19 | 99,987 | $2.1M | 15.3% |
| 6 | $21.19 | 50,928 |
| $1.1M |
| 7.8% |
| 7 | $21.19 | 50,928 | $1.1M | 7.8% |
| 8 | $21.19 | 99,987 | $2.1M | 15.3% |
| 9 | $21.76 | 25,103 | $546K | 3.9% |
| 10 | $21.76 | 12,402 | $270K | 1.9% |
| 11 | $21.76 | 12,402 | $270K | 1.9% |
| 12 | $21.76 | 25,103 | $546K | 3.9% |
| Total | $20.76 avg | 666,664 | $13.8M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |